Why Insulet Corporation’s (PODD) Stock Is Down 6.91%
As of Friday, November 06, Insulet Corporation’s PODD share price has dipped by 6.91%, which has investors questioning if this is right time to buy.Michael Rose
| SECTOR | INDUSTRY |
| Health Care | Health Care Equipment & Supplies |
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Michael Rose
Rosalio Madrigal
Tudor Pop
Tudor Pop
Michael Rose
| Share Statistics | PODD | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $10,083.8 | $380.3 | 78% |
|
| Shares Out (Mil) | 69.5 | 41.2 | 54% |
|
| Institutional Ownership | 99.7% | 84.0% | 92% |
|
| Float (Mil) | 69.1 | 35.2 | 53% |
|
| Beta | 1.05 | 0.85 | 63% |
|
| Avg Daily Volume (000s) | 1,488 | 341 | 75% |
|
| Price Change (52-week) |
(56.3%) | 59.6% | 17% |
|
| Growth | PODD | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 24.5% | 11.8% | 86% |
|
| Net Income (5yr) | 105.2% | (5.6%) | 99% |
|
| EPS (5yr) | 103.4% | 10.6% | 99 |
|
| Dividends (5yr) | 0.0% | 0.0% | 0% |
|
| Cash Flow (5yr) | (18.2%) | (16.0%) | 38% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 23 | 25 | 25 | |
| Current EPS | $1.753 | $6.775 | $7.910 | |
| Month Ago EPS | $1.846 | $6.507 | $7.722 | |
| # Rev Up | 0 | 1 | 1 | |
| # Rev Down | 2 | 0 | 0 | |
| Three Months Ago EPS | $1.841 | $6.503 | $7.711 | |
| Year/Year Chg | (13.6%) | 94.7% | 168.1% | |
| Financials | PODD | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $3,189 | $127 | 67% |
|
| Net Income (TTM) (Mil) | $429 | ($9) | 76% |
|
| EPS (TTM) | $6.146 | ($0.300) | 89% |
|
| Operating Cash Flow (TTM) (Mil) | $509 | ($1) | 71% |
|
| Net Cash Flow (TTM) (Mil) | ($173) | $2 | 11% |
|
| Long-Term Debt (Q1) (Mil) | $1,019 | $25 | 66% |
|
| Enterprise Value (Q1) (Mil) | $11,284 | $400 | 76% |
|
| Valuation | PODD | Industry Median |
Percentile (All Stocks) |
|
| P/B | 6.39 | 2.62 | 86% |
|
| P/E | 23.7 | 26.0 | 62% |
|
| Dividend Yield | 0.0% | 0.0% | 0% |
|
| PEG (5yr hist) | 0.2 | 1.3 | 10% |
|
| Ratios | PODD | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 71.9% | 59.1% | 83% |
|
| Net Margin | 13.4% | (4.5%) | 70% |
|
| ROA | 13.3% | (11.0%) | 91% |
|
| ROE | 28.9% | (8.5%) | 87% |
|
| Liabilities to Assets | 53.8% | 45.9% | 47% |
|
| F-Score | 7 | 4 | 82% |
|
Insulet Corporation did not pass any screens on 11/16/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors